Morgan Stanley analyst James Faucette lowered the firm’s price target on Corpay (CPAY) to $356 from $360 and keeps an Equal Weight rating on the shares following the Q2 report. The firm believes the company’s durable organic growth and capital allocation flexibility create an attractive entry point post the recent selloff.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CPAY:
- Crypto Currents: Trump signs executive order to allow crypto in 401(k) plans
- Corpay, Inc. Reports Balanced Q2 Earnings with Growth and Challenges
- Corpay price target lowered to $392 from $414 at Raymond James
- Corpay, Inc. Reports Strong Q2 Growth and Strategic Moves
- Corpay Inc: Positioned for Strong Growth with Strategic Acquisitions and Fintech Innovations